<qa>  What antibody was given independently and in combination with PD-1 antibody?I. To determine a maximum tolerated dose or maximum administrated dose of anti-lymphocyte activation gene-3 LAG-3 antibody BMS-986016 anti-LAG-3 monoclonal antibody BMS-986016 and anti-cluster of differentiation 137 CD137 antibody BMS- 663513 urelumab given independently and in combination with anti-programmed death-1 PD-1 antibody nivolumab, BMS-936558 safely in patients with recurrent glioblastoma multiforme GBM. 